Literature DB >> 20013271

Elevated serum heme oxygenase-1 and insulin-like growth factor-1 levels in patients with Henoch-Schonlein purpura.

Tao Chen1, Zai-Pei Guo, Yu-Hong Zhang, Ying Gao, Hong-Jie Liu, Jing-Yi Li.   

Abstract

The aim of this study is to investigate the levels of heme oxygenase-1 (HO-1), insulin-like growth factor-1 (IGF-1) and oxidative stress parameters including malondialdehyde (MDA), total antioxidant capacity (T-AOC) and the activities of total superoxide dismutase (SOD), glutathione peroxidase (GSH-PX), catalase (CAT) for exploring the correlations between these biological indexes and the clinical manifestations in Henoch-Schonlein purpura (HSP) patients. 36 patients with different phases of HSP and 16 age- and sex-matched controls were enrolled. MDA level, T-AOC and the activities of SOD, GSH-PX and CAT were measured by spectrophotometry. HO-1 and IGF-1 levels were detected by enzyme-linked immunosorbent assay. Significant higher MDA level, lower T-AOC, SOD, GSH-PX activities were shown in active phase of HSP, respectively, compared with those in early resolution phase of HSP (p < 0.001, <0.001, 0.017, <0.001, respectively) and the control subjects (p < 0.001, <0.001, 0.01, 0.008, respectively). HO-1 (both p < 0.001) and IGF-1 (p < 0.001, 0.009, respectively) levels in active phase and early resolution phase of HSP were significantly higher than those in normal controls. The changes of HO-1 and IGF-1 levels were coincident with overall clinical scores (r = 0.71, p < 0.001; r = 0.615, p < 0.001, respectively). The HO-1 level was found as positive correlation with MDA levels (r = 0.395, p = 0.017), but negative correlations with T-AOC (r = -0.409, p = 0.013) and SOD activities (r = -0.352, p = 0.035). HO-1 and IGF-1 were possibly involved in the pathogenesis of HSP; they could be the marker for evaluating the severity of the disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20013271     DOI: 10.1007/s00296-009-1254-3

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  35 in total

Review 1.  The growth hormone/insulin-like growth factor-I system: implications for organ growth and development.

Authors:  S Yakar; J L Liu; D Le Roith
Journal:  Pediatr Nephrol       Date:  2000-07       Impact factor: 3.714

Review 2.  Insulin-like growth factor-1 as a vascular protective factor.

Authors:  Elena Conti; Cinzia Carrozza; Ettore Capoluongo; Massimo Volpe; Filippo Crea; Cecilia Zuppi; Felicita Andreotti
Journal:  Circulation       Date:  2004-10-12       Impact factor: 29.690

3.  IgA1 is the major IgA subclass in cutaneous blood vessels in Henoch-Schönlein purpura.

Authors:  C A Egan; T B Taylor; L J Meyer; M J Petersen; J J Zone
Journal:  Br J Dermatol       Date:  1999-11       Impact factor: 9.302

4.  Tissue-specific effects of statins on the expression of heme oxygenase-1 in vivo.

Authors:  Mark Hsu; Lucie Muchova; Ichiro Morioka; Ronald J Wong; Henning Schröder; David K Stevenson
Journal:  Biochem Biophys Res Commun       Date:  2006-03-20       Impact factor: 3.575

Review 5.  Recombinant human insulin-like growth factor-1: a new cardiovascular disease treatment option?

Authors:  E Conti; M B Musumeci; G Egidy Assenza; G Quarta; C Autore; M Volpe
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2008-10

6.  Increased serum levels of insulin-like growth factor (IGF)-1 and IGF-binding protein-3 in Henoch-Schonlein purpura.

Authors:  Bilal Yildiz; Nurdan Kural; Banu Aydin; Omer Colak
Journal:  Tohoku J Exp Med       Date:  2008-04       Impact factor: 1.848

7.  Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case-control study.

Authors:  Anders Juul; Thomas Scheike; Michael Davidsen; Jesper Gyllenborg; Torben Jørgensen
Journal:  Circulation       Date:  2002-08-20       Impact factor: 29.690

Review 8.  Renal and vascular oxidative stress and salt-sensitivity of arterial pressure.

Authors:  R D Manning; S Meng; N Tian
Journal:  Acta Physiol Scand       Date:  2003-11

9.  Increased serum HO-1 in hemophagocytic syndrome and adult-onset Still's disease: use in the differential diagnosis of hyperferritinemia.

Authors:  Yohei Kirino; Mitsuhiro Takeno; Mika Iwasaki; Atsuhisa Ueda; Shigeru Ohno; Akira Shirai; Heiwa Kanamori; Katsuaki Tanaka; Yoshiaki Ishigatsubo
Journal:  Arthritis Res Ther       Date:  2005-03-21       Impact factor: 5.156

10.  Antioxidants protect from atherosclerosis by a heme oxygenase-1 pathway that is independent of free radical scavenging.

Authors:  Ben J Wu; Krishna Kathir; Paul K Witting; Konstanze Beck; Katherine Choy; Cheng Li; Kevin D Croft; Trevor A Mori; David Tanous; Mark R Adams; Antony K Lau; Roland Stocker
Journal:  J Exp Med       Date:  2006-04-10       Impact factor: 14.307

View more
  9 in total

1.  Tumour necrosis factor-like weak inducer of apoptosis (TWEAK), an important mediator of endothelial inflammation, is associated with the pathogenesis of Henoch-Schonlein purpura.

Authors:  T Chen; Z-P Guo; M-M Li; J-Y Li; X-Y Jiao; Y-H Zhang; H-J Liu
Journal:  Clin Exp Immunol       Date:  2011-07-15       Impact factor: 4.330

2.  Association between the haptoglobin and heme oxygenase 1 genetic profiles and soluble CD163 in susceptibility to and severity of human malaria.

Authors:  Vitor R R Mendonça; Nívea F Luz; Nadja J G Santos; Valéria M Borges; Marilda S Gonçalves; Bruno B Andrade; Manoel Barral-Netto
Journal:  Infect Immun       Date:  2012-01-30       Impact factor: 3.441

3.  Heme oxygenase-1 promotes the persistence of Leishmania chagasi infection.

Authors:  Nívea F Luz; Bruno B Andrade; Daniel F Feijó; Théo Araújo-Santos; Graziele Q Carvalho; Daniela Andrade; Daniel R Abánades; Enaldo V Melo; Angela M Silva; Cláudia I Brodskyn; Manoel Barral-Netto; Aldina Barral; Rodrigo P Soares; Roque P Almeida; Marcelo T Bozza; Valéria M Borges
Journal:  J Immunol       Date:  2012-03-28       Impact factor: 5.422

4.  Increased serum levels of soluble vascular endothelial-cadherin in patients with systemic vasculitis.

Authors:  Tao Chen; Zai-Pei Guo; Na Cao; Sha Qin; Meng-Meng Li; Rui-Zhen Jia
Journal:  Rheumatol Int       Date:  2014-01-28       Impact factor: 2.631

5.  [Clinical effect and mechanism of hemoperfusion in treatment of children with severe abdominal Henoch-Schönlein purpura].

Authors:  Ying Zhu; Yang Dong; Da-Liang Xu; Jia-Yun Jiang; Lin Wu; Rui-Juan Ke; Shao-Han Fang; Yin Peng
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2018-05

6.  Changes of inflammatory mediators and oxidative stress indicators in children with Henoch-Schönlein purpura and clinical effects of hemoperfusion in the treatment of severe Henoch-Schönlein purpura with gastrointestinal involvement in children.

Authors:  Ying Zhu; Yang Dong; Lin Wu; Fang Deng
Journal:  BMC Pediatr       Date:  2019-11-04       Impact factor: 2.125

Review 7.  A Review of the Mechanism of Vascular Endothelial Injury in Immunoglobulin A Vasculitis.

Authors:  Shanshan Xu; Shanshan Han; Yanlin Dai; Long Wang; Xia Zhang; Ying Ding
Journal:  Front Physiol       Date:  2022-03-16       Impact factor: 4.566

8.  TWEAK enhances E-selectin and ICAM-1 expression, and may contribute to the development of cutaneous vasculitis.

Authors:  Tao Chen; Zai-pei Guo; Li Li; Meng-meng Li; Ting-ting Wang; Rui-zhen Jia; Na Cao; Jing-yi Li
Journal:  PLoS One       Date:  2013-02-15       Impact factor: 3.240

9.  Elevated serum levels of visfatin in patients with henoch-schönlein purpura.

Authors:  Na Cao; Tao Chen; Zai-Pei Guo; Meng-Meng Li; Xiao-Yan Jiao
Journal:  Ann Dermatol       Date:  2014-06-12       Impact factor: 1.444

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.